Quality of life of extremely preterm school-age children without major handicap: a cross-sectional observational study.


Journal

Archives of disease in childhood
ISSN: 1468-2044
Titre abrégé: Arch Dis Child
Pays: England
ID NLM: 0372434

Informations de publication

Date de publication:
04 2019
Historique:
received: 24 02 2018
revised: 07 06 2018
accepted: 14 06 2018
pubmed: 2 7 2018
medline: 7 1 2020
entrez: 2 7 2018
Statut: ppublish

Résumé

To determine the quality of life (QoL) of school-aged children who were born <28 A cross-sectional multicentre study of extremely preterm (EPT) infants born <28 Clinical examination, an assessment of cognitive functions and QoL between 7 and 10 years of age. 40 (7.5%) severely disabled children were excluded. Among those 471 eligible, the lost to follow-up group (169 (36%)) paralleled those 302 (64%) included in the study. The mean gestational age was 26.2 (±0.8), birth weight was 879 (±181) g and the mean age was 8.4 (±0.87) years. 48% of participants had minor or moderate cognitive disabilities based on their Full-Scale Index Quotient. Working memory, attention and mental flexibility scored as low-average. Except for family relationships, the EPT QoL VSP-A and Kidscreen 10 assessment were significantly lower based on the children's and parent's perspectives. Children reported the most significant QoL decline as (1) friends' relationships, (2) self-esteem and (3) leisure, while parents indicated (1) psychological well-being, (2) schoolwork and (3) vitality. The QoL of a school-age EPT child without severe impairment was lower relative to a reference population from both the parents' and child's points of view. This evaluation should help to better understand the long-term outcomes and to provide better support for them and their families. NCT01675726, pre-results.

Identifiants

pubmed: 29960997
pii: archdischild-2018-315046
doi: 10.1136/archdischild-2018-315046
doi:

Banques de données

ClinicalTrials.gov
['NCT01675726']

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

333-339

Investigateurs

M C Lemarchand (MC)
N Mestre (N)
M Rebattel (M)
J C Rozé (JC)
C Coudronnières (C)
G Menard (G)
M Pache (M)
C Morando (C)
M A Einaudi (MA)

Commentaires et corrections

Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Catherine Gire (C)

Department of Neonatology, North Hospital, APHM University Hospital, Marseille, France.
Public Health Department-Research Unit EA3279, Aix-Marseille University, Marseille, France.

Noémie Resseguier (N)

Public Health Department-Research Unit EA3279, Aix-Marseille University, Marseille, France.

Véronique Brévaut-Malaty (V)

Department of Neonatology, North Hospital, APHM University Hospital, Marseille, France.

Stéphane Marret (S)

Department of Neonatal Medicine, Neuropediatrics, Rouen University Hospital and INSERM U1245, Neovasc Team, Perinatal Neurological Handicap and Neuroprotection IRIB, Faculty of Medicine, Rouen University, Rouen, France.

Gilles Cambonie (G)

Department of Neonatal Medicine, Montpellier University Hospital, Montpellier, France.

Isabelle Souksi-Medioni (I)

Department of Neonatal Medicine, Nimes University Hospital, Nimes, France.

Jean-Baptiste Müller (JB)

Department of Neonatal Medicine, Nantes University Hospital, Nantes, France.

Patricia Garcia (P)

Department of Neonatology, Conception Hospital, APHM University Hospital, Marseille, France.

Julie Berbis (J)

Public Health Department-Research Unit EA3279, Aix-Marseille University, Marseille, France.

Barthélémy Tosello (B)

Department of Neonatology, North Hospital, APHM University Hospital, Marseille, France.
Aix-Marseille University, CNRS, EFS, ADES, Marseille, France.

Pascal Auquier (P)

Public Health Department-Research Unit EA3279, Aix-Marseille University, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH